Solence Secures $1.6M Seed Round to Revolutionize PCOS Management with Evidence-Based Lifestyle Solutions

Solence is thrilled to announce that we have raised 1,600,000 in our latest funding round—a major milestone that underscores investor confidence in our innovative approach to women's health. At Solence, we are dedicated to empowering women by providing an evidence-based program designed to reverse PCOS symptoms through sustainable lifestyle changes. Our platform offers interactive lessons that guide users through personalized journeys to understand and manage their condition, bridging the gap between complex medical research and everyday wellness practices. The funding will enable us to expand our product offerings, enhance our digital infrastructure, and reach a broader audience, ensuring that more women have access to resources that demystify the challenges of PCOS. In addition to our comprehensive lifestyle modules, Solence features a unique PCOS assessment toolbox that helps users map out their symptoms and identify trigger factors effectively. This tool not only supports self-monitoring but also encourages users to engage with their healthcare providers more proactively. With these resources, users can track their progress, set achievable health goals, and make more informed decisions about their treatment options. The new investment will accelerate our research and development initiatives as well as enhance our community outreach and educational campaigns, fostering an environment of support and empowerment for women everywhere. We invite you to learn more about our mission and explore our app available on the App Store here: https://apps.apple.com/fr/app/solence-sopk/id6450059867. This funding milestone marks the beginning of an exciting new chapter for Solence, as we continue to innovate and create positive change in the lives of women battling PCOS.